找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Nanomedicines for Effective Cancer Therapy; Hitoshi Kasai,Hiroshi Uji-i,Johan Hofkens Book 2024 The Editor(s) (if applicable) and The Auth

[復(fù)制鏈接]
樓主: Forestall
31#
發(fā)表于 2025-3-26 23:09:01 | 只看該作者
Targeted Drug Delivery for Cancer Therapy Using Functionalized Nanocarrierse therapies are based on passive accumulation in tumor tissues via enhanced permeability of tumor vasculature, namely the enhanced permeability and retention effect (EPR effect). However, the efficacy of EPR-based drug delivery is controversial because liposomal doxorubicin potentially has an insuf
32#
發(fā)表于 2025-3-27 02:24:08 | 只看該作者
Cancer Photo Therapies that Target Mitochondriapeutic molecule of choice to act where it is needed and for the required time. Cancer photo therapy typically involves photochemical reactions induced by light irradiation to cause cell death. Over the past few decades, mitochondria have attracted considerable attention in the field of therapy. The
33#
發(fā)表于 2025-3-27 05:54:26 | 只看該作者
34#
發(fā)表于 2025-3-27 12:23:45 | 只看該作者
35#
發(fā)表于 2025-3-27 13:43:27 | 只看該作者
36#
發(fā)表于 2025-3-27 19:25:00 | 只看該作者
Cell Membrane Mimetic Amphiphilic Phospholipid Polymers for Advanced Nanomedicinee, we introduce phospholipid polymers, whose molecular design is based on the surface structure of cell membranes, and their role in drug formulation. These phospholipid polymers are amphiphilic, can substantially enhance the solubility of drugs in aqueous media, and can permeate membranes through m
37#
發(fā)表于 2025-3-27 23:17:52 | 只看該作者
38#
發(fā)表于 2025-3-28 04:45:33 | 只看該作者
39#
發(fā)表于 2025-3-28 08:14:50 | 只看該作者
3D Tumor Models—Nanomedicine in the Third Dimensionnced efficacy and reduced side effects has marked a significant step forward in cancer research. However, the promising results observed in preclinical studies show low translatability into the clinic, due to a lack of adequate preclinical models that faithfully mimic the complex tumor microenvironm
40#
發(fā)表于 2025-3-28 11:55:16 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-15 20:51
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
邯郸市| 汾西县| 蓬莱市| 威宁| 长治市| 广州市| 格尔木市| 宣化县| 高阳县| 望江县| 时尚| 林周县| 崇州市| 南宫市| 成都市| 郧西县| 秦安县| 无锡市| 康乐县| 河南省| 涪陵区| 中卫市| 钟山县| 澄城县| 巨鹿县| 丰原市| 衡阳县| 合水县| 辽中县| 芦溪县| 腾冲县| 蒙自县| 九龙县| 搜索| 越西县| 全南县| 江油市| 广安市| 祁阳县| 珠海市| 霍邱县|